https://aijourn.com/blacksmith-medicines-co-founder-presents-at-the-21st-international-conference-on-biological-inorganic-chemistry/
Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor
co founderinternational conferenceblacksmithmedicinespresents
https://www.helsinki.fi/en/helsinki-innovation-services/industry-and-investors/commercialisation-projects/mitoguarder-enhances-production-biological-medicines-innovative-technology
A new technology is being developed which has the potential to modify cells in order to relieve stress and enable them to produce biological medicines for...
biological medicinesinnovative technologyenhancesproduction